UNIPHARMA ApS: Financial statements 2014
CVR: 78881917
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -6,313 and a net result of DKK -6,313 compared with DKK -6,187 the year before. Equity amounted to DKK 98,813. The solvency ratio was 54.7%.
- Gross Profit
- -6,313 kr.
- Profit/Loss
- -6,313 kr.
- Equity
- 98,813 kr.
- Total Assets
- 180,490 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -6 t. | -6 t. | 99 t. | - |
| 2013 | - | -6 t. | -6 t. | 105 t. | - |
| 2012 | - | -5 t. | -5 t. | 111 t. | - |
Keep an eye on UNIPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
UNIPHARMA ApS has published its annual report for 2013. Gross profit came to DKK -6,187, and the net result was DKK -6,187.
As of May 22, 2014, Peter Reumert is registered as adm. dir. of UNIPHARMA ApS.
As of May 22, 2014, Ebba Dorrit Reumert is registered as adm. dir. of UNIPHARMA ApS.
As of May 22, 2014, Jørgen de Muzquiz Reumert has stepped down as director of UNIPHARMA ApS.
As of May 22, 2014, Ebba Dorrit Reumert has stepped down as adm. dir. of UNIPHARMA ApS.
About UNIPHARMA ApS
UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.
